GENPREX (GNPX) vs NexImmune, Inc. (NEXI)
- GENPREX GNPX 2.11 −7.86%
- NexImmune, Inc. NEXI 0.00 NaN
GENPREX and NexImmune, Inc. are both Biotechnology companies. GENPREX is the larger, with a market value of $1.9M against $1.6M — 1.2× the size. NexImmune, Inc. has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 7 metrics below, GENPREX leads on 4 and NexImmune, Inc. on 3.
Valuation
Profitability
| Metric | GNPX | NEXI | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (203.86%) | (232.97%) | (56.36%) |
| Return on assets | (157.40%) | (140.56%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack